Real-World Evidence FDA’s Jacqueline Corrigan-Curay
Executive Summary
In a podcast interview, US FDA Office of Medical Policy Director Jacqueline Corrigan-Curay talks about FDA’s current work on real-world evidence.
You may also be interested in...
Real World Evidence: Between 'Nirvana' And Electronic Roadblocks
US FDA's Jonathan Jarow says it will be up to pharma industry to get right data into electronic health records.
A Final Push For US Hepatitis C Eradication Plan In 2024
The Biden Administration is hoping that it can attach funding for a national hepatitis C ‘subscription’ program into the delayed fiscal 2024 appropriations bills.
Menopausal Status Is Another Focus For US FDA Trial Inclusion Efforts
US FDA is emphasizing the need to assess the effects of menopause on drug safety and efficacy as a continuation of the agency’s efforts to encourage clinical trial sponsors to look more systematically for differences in clinical trial subpopulations.